PUMA BIOTECHNOLOGY, INC. Quarterly Nonoperating Income (Expense) in USD from Q3 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Puma Biotechnology, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2011 to Q2 2024.
  • Puma Biotechnology, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$1.97M, a 23.5% increase year-over-year.
  • Puma Biotechnology, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was -$8.84M, a 62.2% increase year-over-year.
  • Puma Biotechnology, Inc. annual Nonoperating Income (Expense) for 2023 was -$9.97M, a 57.2% increase from 2022.
  • Puma Biotechnology, Inc. annual Nonoperating Income (Expense) for 2022 was -$23.3M, a 22.7% increase from 2021.
  • Puma Biotechnology, Inc. annual Nonoperating Income (Expense) for 2021 was -$30.1M, a 2.4% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$8.84M -$1.97M +$607K +23.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 -$9.45M -$2.3M +$521K +18.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 -$9.97M -$1.99M +$13.3M +87% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 -$23.3M -$2.58M +$110K +4.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 -$23.4M -$2.58M +$51K +1.94% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 -$23.5M -$2.82M -$198K -7.56% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 -$23.3M -$15.3M -$12.9M -540% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 -$10.3M -$2.69M +$33M +92.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$43.3M -$2.63M -$14.2M -123% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 -$29.1M -$2.62M +$961K +26.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$30.1M -$2.4M +$1.24M +34.1% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 -$31.3M -$35.7M -$16.3M -84.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$15M $11.6M +$15.3M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$30.3M -$3.58M -$898K -33.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$29.4M -$3.64M -$1.16M -46.6% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-02
Q3 2020 -$28.2M -$19.3M -$16.9M -693% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$11.3M -$3.73M +$7.91M +67.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$19.2M -$2.68M +$17.3M +86.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$36.5M -$2.48M +$9.66M +79.6% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-03
Q3 2019 -$46.2M -$2.44M +$483K +16.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$46.6M -$11.6M -$8.75M -303% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$37.9M -$19.9M -$19M -1996% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$18.9M -$12.1M -$11.6M -2271% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 -$7.27M -$2.92M -$3.18M -1223% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$4.09M -$2.89M -$3.24M -926% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$853K -$951K -$1.29M -382% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $435K -$512K -$721K -345% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-28
Q3 2017 $1.16M $260K +$42K +19.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 $1.11M $350K +$466K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $648K $337K +$63K +23% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $585K $209K -$107K -33.9% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-01
Q3 2016 $692K $218K -$98K -31% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $790K -$116K -$335K -153% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $1.13M $274K +$129K +89% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $996K $316K +$207K +190% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-09
Q3 2015 $789K $316K +$201K +175% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $588K $219K +$158K +259% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $430K $145K +$120K +480% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $310K $109K +$66K +153% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 $244K $115K +$67K +140% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $177K $61K +$4K +7.02% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $173K $25K -$1K -3.85% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 $174K $43K +$8K +22.9% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 $166K $48K +$34K +243% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 $132K $57K +$34K +148% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-11
Q1 2013 $98K $26K $0 0% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 $98K $35K Oct 1, 2012 Dec 31, 2012 10-K 2015-03-02
Q3 2012 $14K +$27.5K Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $23K Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-06
Q1 2012 $26K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q3 2011 -$13.5K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.